Massive Bio’s Post

🚀 We're excited to announce the launch of Patient Connect, a free and innovative portal designed to help cancer patients navigate the complex clinical trial landscape globally. Using our AI-powered matching system, patients can now find the most suitable clinical trials based on their unique diagnosis, biomarkers, and treatment history, regardless of location or financial constraints. With over 132,000 patients onboard and access to nearly 16,000 trials, Patient Connect offers personalized trial matching reports that can be shared with physicians and loved ones. This is a major step toward democratizing access to cancer care and bringing hope to patients worldwide. Learn more about Patient Connect here: https://lnkd.in/dTyHDcRd #CancerCare #ClinicalTrials #AI #PatientConnect #HealthcareInnovation Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD, Oz Huner

As ESMO 2024 comes to a close, we reflect on an incredible week of connection, innovation, and collaboration. It’s been an honor to showcase how Massive Bio is at the forefront of transforming cancer care through technology and AI powered clinical trial matching. We’ve had the privilege of engaging with so many brilliant minds who are as dedicated as we are to making a difference in oncology. A heartfelt thank you to everyone who visited us at booth #431 and shared in these meaningful conversations. Together, we’re driving the future of cancer treatment forward. Massive Bio is at ESMO 2024: https://lnkd.in/dKQwsHZF #ESMO2024 #Oncology #Innovation #AIinHealthcare Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD, Oz Huner, Mert Sari, Gisela Saladino

Our team had the privilege of meeting with top healthcare professionals during the ESMO conference to discuss future partnerships and innovative opportunities.   Together, we explored key areas for growth, collaboration, and advancing patient care, including potential roundtables and panel discussions we will organize in the near future.   We had an exciting dinner with passionate professionals who share our vision for advancing healthcare and oncology research. Massive Bio is at ESMO 2024: https://lnkd.in/dKQwsHZF #ESMO2024 #Oncology #Innovation #AIinHealthcare Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu, Oz Huner, Mert Sari, Gisela Saladino

Day three at ESMO 2024 is in full swing, and our booth is buzzing with energy! ⚡ At Massive Bio, we’re excited to showcase how our innovative technology is transforming cancer care. From groundbreaking clinical trials to personalized treatment strategies, we're eager to connect with passionate professionals dedicated to advancing oncology. Our products are leading the way in reshaping cancer care, and we’re excited to share all the latest developments. If you’re attending ESMO, don’t miss the chance to visit us at booth #431. Massive thanks to Mert Sari, Our Director for OUS Provider Engagement, and Gisela Saladino, our Account Manager for Spain, for sharing their insights and engage with attendees. Massive Bio is at ESMO 2024: https://lnkd.in/dKQwsHZF #ESMO2024 #Oncology #Innovation #AIinHealthcare Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD

Our team is proud to be on the ground at ESMO 2024, engaging with oncology experts and fostering conversations that drive innovation in cancer care. Stop by Booth #431 to discover how we are simplifying access to breakthrough therapies and research. Together, we’re making strides to shape a brighter future in oncology. Special shoutout to Oz Huner, our VP, Head of Product, and Gisela Saladino, our Account Manager for Spain, for their dedication at this important event! Learn more: https://lnkd.in/duttTzp9 #ESMO2024 #OncologyInnovation #MassiveBio Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD, Oz Huner, Gisela Saladino

Our team is actively engaging with professionals from around the world at the #ESMO 2024 Congress. This prestigious event is a key opportunity to share knowledge, foster collaborations, and explore the latest breakthroughs in oncology. We’re proud to be part of these important discussions that are shaping the future of cancer care. Visit us at Booth #431 to connect with us and learn more about our innovative approaches in oncology. Massive Bio is at ESMO 2024: https://lnkd.in/dKQwsHZF #ESMO2024 #OncologyInnovation #MassiveBio Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD

We are thrilled to announce our strategic partnership with Foundation Medicine to enhance clinical trial recruitment and expand access to precision cancer care. This collaboration combines Massive Bio's AI-driven trial matching technology with Foundation Medicine’s genomic profiling expertise. Together, we aim to significantly improve clinical trial enrollment rates. Dr. Arturo LoAIza-Bonilla MD, Co-founder and Chief Medical Officer, emphasizes the transformative potential: "Our combined technologies will accelerate patient access to personalized treatments, changing the landscape of cancer care." For more information about this groundbreaking partnership and its impact on oncology, visit our website at https://lnkd.in/dc_UzyEx Together, we are setting new standards in the field, ensuring advanced therapies reach patients faster and more efficiently. 🌐🔍 #MassiveBio #FoundationMedicine #Oncology #CancerTreatment #AIinHealthcare Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD

The #ESMO Congress 2024 is a great opportunity for Massive Bio to connect with the oncology community. Meet our co-founders at Booth #431 to discuss patient enrollment challenges and learn about our innovative, AI-powered solutions. Also, we're excited to join the OncoDaily Party and meet professionals from around the world! Don’t miss the chance to meet the Massive Bio team and discover how we're shaping the future of oncology. Learn more: https://lnkd.in/dKQwsHZF #ESMO2024 #OncologyInnovation #MassiveBio #OncoDaily Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD